Investigation of effects of fluoxetine on the bronchial smooth muscles by the isolated organ bath system.

Airway smooth muscles (ASMs) play an essential role during breathing by contracting and relaxing as needed. Its dysfunction is related to some diseases such as asthma. The contractile mechanism of ASMs is complex. Therefore, research is necessary for this domain to identify issues and chemicals that can affect their contractions and impose health threats. This study aimed to investigate the effects of fluoxetine on the smooth muscles of the ASM using an isolated organ bath system. Fifteen male Sprague Dawley rats were divided into three groups: acetylcholine (ACh) group, fluoxetine group, and ACh + fluoxetine group. Following decapitation, 1-cm-long smooth muscle strips were prepared and placed in the isolated organ bath system Krebs' solution at 37 °C (pH = 7.4), constantly bubbled with oxygen/carbon dioxide mixture (95%:5%), and isometric contractions were recorded. Contraction of the smooth muscle was achieved by 10-µM Ach, and contractile/relaxation effects of cumulative concentrations of fluoxetine (10-9-10-1 M) were investigated. There was a numerical decrease in the contraction compared to ACh with no statistical significance in the ACh-fluoxetine group. There was a significant difference between the fluoxetine and the ACh groups (p < 0.05). In conclusion, fluoxetine had no contractile effect on ASM in isolated organ bath systems. Future studies are needed to evaluate the effects of oral usage of fluoxetine on the bronchial muscle in different experimental models to explain the adverse/beneficial effects of fluoxetine in the subjects, especially with respiratory conditions.

HMG-CoA Reductase Inhibition Promotes Neurological Recovery, Peri-Lesional Tissue Remodeling, and Contralesional Pyramidal Tract Plasticity after Focal Cerebral Ischemia.

3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors are widely used for secondary stroke prevention. Besides their lipid-lowering activity, pleiotropic effects on neuronal survival, angiogenesis, and neurogenesis have been described. In view of these observations, we were interested whether HMG-CoA reductase inhibition in the post-acute stroke phase promotes neurological recovery, peri-lesional, and contralesional neuronal plasticity. We examined effects of the HMG-CoA reductase inhibitor rosuvastatin (0.2 or 2.0 mg/kg/day i.c.v.), administered starting 3 days after 30 min of middle cerebral artery occlusion for 30 days. Here, we show that rosuvastatin treatment significantly increased the grip strength and motor coordination of animals, promoted exploration behavior, and reduced anxiety. It was associated with structural remodeling of peri-lesional brain tissue, reflected by increased neuronal survival, enhanced capillary density, and reduced striatal and corpus callosum atrophy. Increased sprouting of contralesional pyramidal tract fibers crossing the midline in order to innervate the ipsilesional red nucleus was noticed in rosuvastatin compared with vehicle-treated mice, as shown by anterograde tract tracing experiments. Western blot analysis revealed that the abundance of HMG-CoA reductase was increased in the contralesional hemisphere at 14 and 28 days post-ischemia. Our data support the idea that HMG-CoA reductase inhibition promotes brain remodeling and plasticity far beyond the acute stroke phase, resulting in neurological recovery.